RSETGHO
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RSETGHO Trademark

Serial Number: 88607066

RSETGHO is a trademark filed by Ascendis Pharma Endocrinology Division A/S on September 6, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Ascendis Pharma Endocrinology Division A/S (14 trademarks)

Hellerup 2900 , DK

Entity Type: 99

Trademark Details

Filing Date

September 6, 2019

Registration Date

Not Registered

Published for Opposition

May 26, 2026

Goods & Services

Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases

Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 29, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 29, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 29, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 29, 2026 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 13, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 13, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 13, 2026 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 8, 2026 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 6, 2026 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 17, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 15, 2025 CRFA
ASSIGNED TO LIE
Dec 15, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 1, 2025 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 20, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 19, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 16, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 19, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 20, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 20, 2023 RCSC
ASSIGNED TO EXAMINER
Mar 10, 2023 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 31, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 31, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
May 31, 2022 GNSL
SUSPENSION LETTER WRITTEN
May 31, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 26, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 26, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 16, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 15, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 15, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 15, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 18, 2021 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 1, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 1, 2021 GNSL
SUSPENSION LETTER WRITTEN
Apr 1, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2021 CRFA
ASSIGNED TO LIE
Mar 2, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 25, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 29, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 29, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 29, 2020 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 6, 2020 RCCK
ASSIGNED TO LIE
Aug 6, 2020 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 14, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 14, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jan 14, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 27, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 27, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 18, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 18, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 18, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 9, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2019 NWOS
NEW APPLICATION ENTERED
Sep 10, 2019 NWAP